交易 Lonza Group Ltd - LONN 差價合約
Lonza Group AG (SWX: LONN) is a Swiss contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotech industries. Specializing in biologics, cell and gene therapies, and small molecule APIs, Lonza plays a critical role in scaling complex therapies. With long-term client contracts and global facilities, the company benefits from rising biotech outsourcing and specialty medicine demand. Lonza offers investors a high-quality life sciences supplier with resilient, innovation-led growth.最新股票文章

收息股:股息率分布、選股風險框架與高息ETF配置分析
2026年港股收息股與高息ETF的股息率結構、派息可持續性風險、估值環境及行業分散配置邏輯,涵蓋銀行股、REITs、公用事業及能源板塊的風險收益特徵分析
08:35, 27 3月 2026

平頭哥分拆上市分析:阿里巴巴AI芯片業務的結構性風險與估值框架
阿里巴巴旗下平頭哥半導體擬分拆獨立上市,摩根大通估值介於250億至620億美元。本文從業務依賴度、估值方法論、地緣政策風險及港股科技板塊估值溢價等維度,解構該交易的結構性風險與分析框架。
14:16, 11 3月 2026

